OF THE DISCLOSUREORGANIC COMPOUNDSThe present invention relates to a pharmaceutical composition comprising a sphingosine-1phosphate receptor agonist and a sugar alcohol. Such a composition has goodphysicochemical and storage properties and is particularly well suited for oral administration ofSIP-1 receptor agonists. In particular, the composition as disclosed herein shows a high levelof uniformity in the distribution of the S1 P receptor agonist throughout the composition.no suitable Figure
